An analysis of national news coverage of semaglutide for weight loss.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- An analysis of national news coverage of semaglutide for weight loss.
- Published In:
- Journal of the American Pharmacists Association : JAPhA, 65(1), 102297 (2025)
- Authors:
- Gionfriddo, Michael R, Owens, Katelyn M, Banks, Hannah, Sherigar, Anwitha, Covvey, Jordan R
- Database ID:
- RPEP-11107
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11107APA
Gionfriddo, Michael R; Owens, Katelyn M; Banks, Hannah; Sherigar, Anwitha; Covvey, Jordan R. (2025). An analysis of national news coverage of semaglutide for weight loss.. Journal of the American Pharmacists Association : JAPhA, 65(1), 102297. https://doi.org/10.1016/j.japh.2024.102297
MLA
Gionfriddo, Michael R, et al. "An analysis of national news coverage of semaglutide for weight loss.." Journal of the American Pharmacists Association : JAPhA, 2025. https://doi.org/10.1016/j.japh.2024.102297
RethinkPeptides
RethinkPeptides Research Database. "An analysis of national news coverage of semaglutide for wei..." RPEP-11107. Retrieved from https://rethinkpeptides.com/research/gionfriddo-2025-an-analysis-of-national
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.